Biomarker-Driven Therapy for NSCLC: Experts Discuss Current and Future Trends

Gain expert guidance on optimal use of biomarkers to guide treatment decisions for advanced NSCLC with this educational program featuring an on-demand webcast and downloadable slidesets from a live CCO webinar along with a podcast of the experts answering questions from the audience.

Share

Program Content

No activities added yet

Activities

NSCLC Biomarkers: Frontline SoC TKIs
Leveraging Established Predictive Biomarkers for Optimal Use of Frontline Targeted Therapies in NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 14, 2021

Expires: April 13, 2022

NSCLC Biomarkers: Emerging Targeted Therapies
Emerging Predictive Biomarkers for Targeted Therapies in NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 14, 2021

Expires: April 13, 2022

NSCLC Biomarkers: Overview and IO
Overview of Biomarker Testing in NSCLC and Biomarkers Predicting Response to Immune-Based Therapies
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 14, 2021

Expires: April 13, 2022

<i>ExpressPoints</i>: NSCLC Biomarkers
ExpressPoints Biomarker-Driven Therapy for NSCLC: Experts Discuss Current and Future Trends
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 21, 2021

Expires: April 20, 2022

Activities

FAQ: NSCLC Biomarkers
Experts Answer FAQs on Biomarker-Driven Therapy for Non-Small-Cell Lung Cancer
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: May 19, 2021

Expires: May 18, 2022

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Lilly

Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme